Combined PD-1 and JAK1/2 inhibition in refractory primary mediastinal B-cell lymphoma
Crossref DOI link: https://doi.org/10.1007/s00277-018-3233-9
Published Online: 2018-01-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nijland, Marcel http://orcid.org/0000-0002-2740-2873
van Meerten, Tom
Seitz, Annika
Huls, Gerwin
Kibbelaar, Robby
Visser, Lydia
van den Berg, Anke
Diepstra, Arjan
License valid from 2018-01-11